| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/24/2001 | US6221585 Detection of transcripts which determine preferential phenotype; remove nonfitting hybridization products, classify transcripts associated with preferential phenotype |
| 04/24/2001 | US6221584 Method of detecting telomerase activity |
| 04/24/2001 | US6221583 Use of nucleic acids containing electron transfer moieties to be used as nucleic acid probes; probe nucleic acid is covalently attached to an electrode via a conductive oligomer |
| 04/24/2001 | US6221582 Uitilization of nucleotide sequences to classify bacterial cells |
| 04/24/2001 | US6221581 Screening for nucleotide sequences of interest; mixing probes and preferential nucleotide sequences, allow complexes to form, recover complexes, washing to remove impurities, screen for signal |
| 04/24/2001 | US6221580 Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease |
| 04/24/2001 | US6221355 Anti-pathogen system and methods of use thereof |
| 04/24/2001 | US6221319 Plasma discharge reactors for the preparation of bioactive compounds |
| 04/24/2001 | US6221315 Centrifuge, blood, |
| 04/24/2001 | US6221238 Enzymatic-electrochemical one-shot affinity sensor for the quantitative determination of analytes for aqueous media and affinity assay |
| 04/24/2001 | US6219964 Method for identifying genetic marker loci associated with trait loci |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2147618C Probe for diagnosing of infectious diseases |
| 04/24/2001 | CA1341216C Human .alpha.-1-antitrypsin derivatives, and a production process |
| 04/21/2001 | CA2321266A1 Anti-dnase-gamma antibody, and production and use thereof |
| 04/19/2001 | WO2001027857A2 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 04/19/2001 | WO2001027635A1 Multiwell scanner and scanning method |
| 04/19/2001 | WO2001027629A1 Diagnosis of pathologies of mononucleated blood cells |
| 04/19/2001 | WO2001027628A1 Antibiotic-metal complexes in the detection of gram-negative bacteria and other biological analytes |
| 04/19/2001 | WO2001027625A1 Conjugated polymer tag complexes |
| 04/19/2001 | WO2001027624A2 Compositions and methods for detecting protein modification and enzymatic activity |
| 04/19/2001 | WO2001027614A1 Method and device for taking measurements of cells which are contained in a liquid environment |
| 04/19/2001 | WO2001027334A2 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | WO2001027333A1 Sodd gene expression in cancer |
| 04/19/2001 | WO2001027332A1 Pcr-based method for identifying a fusarium wilt-resistant genotype in plants |
| 04/19/2001 | WO2001027331A2 Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| 04/19/2001 | WO2001027330A2 Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes |
| 04/19/2001 | WO2001027329A2 Combinatorial oligonucleotide pcr: a method for rapid, global expression analysis |
| 04/19/2001 | WO2001027328A1 Particle analysis assay for biomolecular quantification |
| 04/19/2001 | WO2001027327A2 Method and apparatus for performing large numbers of reactions using array assembly |
| 04/19/2001 | WO2001027326A2 Template-dependent ligation with pna-dna chimeric probes |
| 04/19/2001 | WO2001027325A1 Marker assisted identification of a gene associated with a phenotypic trait |
| 04/19/2001 | WO2001027324A2 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | WO2001027323A1 Method of screening for susceptibility to drug-induced cardiac arrhythmia |
| 04/19/2001 | WO2001027322A2 Chitobiase as a reporter enzyme |
| 04/19/2001 | WO2001027321A2 Method for detecting differences in gene expression of wild type plants and genetically modified plants |
| 04/19/2001 | WO2001027320A1 SUSPENSION SYSTEM FOR SEQUENCING GENETIC SUBSTANCE, METHOD OF SEQUENCING GENETIC SUBSTANCE BY USING THE SUSPENSION SYSTEM, AND METHOD OF HIGH-SPEED SNPs SCORING BY USING THE SUSPENSION SYSTEM |
| 04/19/2001 | WO2001027319A2 Leptin assay based on detecting ang-2 expression |
| 04/19/2001 | WO2001027318A2 Reverse transcriptase assay |
| 04/19/2001 | WO2001027317A2 Method for distinguishing 5-position methylation changes |
| 04/19/2001 | WO2001027316A1 Luminescence test system |
| 04/19/2001 | WO2001027315A2 For substances acting on msk1 or msk2 |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001027313A2 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene |
| 04/19/2001 | WO2001027312A2 Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene |
| 04/19/2001 | WO2001027311A2 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027285A1 A novel polypeptide, a human dpb methyltransferase 41 and the polynucleotide encoding the polypeptide |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027272A1 Oculomedin and glaucoma |
| 04/19/2001 | WO2001027271A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | WO2001027269A2 Vip54 protein and related materials |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027266A1 Dna segments that are useful for selecting differentiated cell types and the applications thereof |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027263A1 Modulate aptamer and method for detecting target protein by using the same |
| 04/19/2001 | WO2001027262A1 Gene selection using pnas |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027253A1 Use of nernstein voltage sensitive dyes in measuring transmembrane voltage |
| 04/19/2001 | WO2001027246A1 Novel human potassium channel subunit |
| 04/19/2001 | WO2001027243A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 04/19/2001 | WO2001027242A2 Methods for identifying inhibitors of methionine aminopeptidases |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026673A1 Antibiotic-metal complex and methods |
| 04/19/2001 | WO2001026575A1 Methods of diagnosing and treating urinary incontinence |
| 04/19/2001 | WO2001026536A2 Methods of diagnosing and treating hepatic cell proliferative disorders |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001002558A8 Probe for analysis of nucleic acids |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000078986B1 Regulation system of expression using nuclear ppar receptors |
| 04/19/2001 | WO2000075360A3 Method and apparatus for enzyme detection |
| 04/19/2001 | WO2000071987A3 Isolation and culturing of fetal cells |
| 04/19/2001 | WO2000070086A9 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000065523A8 System and method for modeling genetic, biochemical, biophysical and anatomical information |
| 04/19/2001 | WO2000057187A3 Diagnosis and treatment of multiple sclerosis |
| 04/19/2001 | WO2000047236A8 Matrices for drug delivery and methods for making and using the same |
| 04/19/2001 | WO2000033161A9 Methods to reduce variance in treatment studies using genotyping |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000029444A9 Generation of antibodies using polynucleotide vaccination in avian species |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | DE19949059A1 Functional description of DNA, useful e.g. for identifying new coding sequences, comprises assigning characteristic values to individual bases derived from vibrational properties |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2387560A1 Diagnosis of pathologies of mononucleated blood cells |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387355A1 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | CA2387237A1 Novel human potassium channel subunit |
| 04/19/2001 | CA2387188A1 Vip54 protein and related materials |
| 04/19/2001 | CA2387148A1 Method for distinguishing 5-position methylation changes |
| 04/19/2001 | CA2387126A1 Methods for identifying inhibitors of methionine aminopeptidases |
| 04/19/2001 | CA2387035A1 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 04/19/2001 | CA2386824A1 Methods and compositions for targeting a cell |
| 04/19/2001 | CA2386791A1 Method and apparatus for performing large numbers of reactions using array assembly |
| 04/19/2001 | CA2386410A1 Combinatorial oligonucleotide pcr: a method for rapid, global expression analysis |
| 04/19/2001 | CA2386365A1 Leptin assay |
| 04/19/2001 | CA2386299A1 Antiprotozoal histone acetyl transferase inhibitors |